iron heme polypeptide sustained release
Selected indexed studies
- The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients. (Int J Cancer, 2022) [PMID:36054818]
- Design and synthesis of isothiocyanate-containing hybrid androgen receptor (AR) antagonist to downregulate AR and induce ferroptosis in GSH-Deficient prostate cancer cells. (Chem Biol Drug Des, 2021) [PMID:33470049]
_Worker-drafted node — pending editorial review._
Connections
iron heme polypeptide sustained release helps
Sources
- The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients. (2022) pubmed
- Design and synthesis of isothiocyanate-containing hybrid androgen receptor (AR) antagonist to downregulate AR and induce ferroptosis in GSH-Deficient prostate cancer cells. (2021) pubmed